NCT04317911View on ClinicalTrials.gov

Catheter Ablation for Atrial Fibrillation in Preserved Ejection Fraction

CompletedOBSERVATIONAL

Enrollment

102

Participants

Timeline

Start Date

January 26, 2016

Primary Completion Date

September 30, 2021

Study Completion Date

February 28, 2022

Conditions

Atrial Fibrillation

Interventions

OTHER

Catheter Ablation

Patients with preserved ejection fraction presenting for catheter ablation via of atrial fibrillation are included in this study and prospectively observed regarding arrhythmia-related, functional and biomarker-associated outcomes.

Trial Locations (1)

Unknown

University Hospital Heidelberg, Department of Cardiology, Heidelberg

All Listed Sponsors

collaborator

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

OTHER

lead

University Hospital Heidelberg

OTHER

NCT04317911 - Catheter Ablation for Atrial Fibrillation in Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter